Richards SJ - Search Results

1

Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age.

Richards SJ, Morgan GJ, Hillmen P. Richards SJ, et al. Blood. 1999 Oct 15;94(8):2790-9. Blood. 1999. PMID: 10515882 Free article.

2

Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.

Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, O'Connor SJ, Richards SJ, Morgan GJ, Jack AS, Hillmen P. Rawstron AC, et al. Among authors: richards sj. Blood. 2002 Jul 15;100(2):635-9. doi: 10.1182/blood.v100.2.635. Blood. 2002. PMID: 12091358 Free article.

3

The glycosylphosphatidylinositol anchor and paroxysmal nocturnal haemoglobinuria/aplasia model.

Hall C, Richards SJ, Hillmen P. Hall C, et al. Among authors: richards sj. Acta Haematol. 2002;108(4):219-30. doi: 10.1159/000065658. Acta Haematol. 2002. PMID: 12432218 Review.

4

Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.

Hill A, Hillmen P, Richards SJ, Elebute D, Marsh JC, Chan J, Mojcik CF, Rother RP. Hill A, et al. Among authors: richards sj. Blood. 2005 Oct 1;106(7):2559-65. doi: 10.1182/blood-2005-02-0564. Epub 2005 Jun 28. Blood. 2005. PMID: 15985537 Free article. Clinical Trial.

5

Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.

Hill A, Ridley SH, Esser D, Oldroyd RG, Cullen MJ, Kareclas P, Gallagher S, Smith GP, Richards SJ, White J, Smith RA, Hillmen P. Hill A, et al. Among authors: richards sj. Blood. 2006 Mar 1;107(5):2131-7. doi: 10.1182/blood-2005-02-0782. Epub 2005 Dec 1. Blood. 2006. PMID: 16322479 Free article.

6

Recent advances in the diagnosis, monitoring, and management of patients with paroxysmal nocturnal hemoglobinuria.

Richards SJ, Hill A, Hillmen P. Richards SJ, et al. Cytometry B Clin Cytom. 2007 Sep;72(5):291-8. doi: 10.1002/cyto.b.20358. Cytometry B Clin Cytom. 2007. PMID: 17549742 Free article. Review.

7

Immunophenotypic analysis of PNH cells.

Richards SJ, Hillmen P. Richards SJ, et al. Curr Protoc Cytom. 2002 May;Chapter 6:Unit 6.11. doi: 10.1002/0471142956.cy0611s20. Curr Protoc Cytom. 2002. PMID: 18770768

8

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P. Kelly RJ, et al. Among authors: richards sj. Blood. 2011 Jun 23;117(25):6786-92. doi: 10.1182/blood-2011-02-333997. Epub 2011 Apr 1. Blood. 2011. PMID: 21460245 Free article. Clinical Trial.

9

Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.

Johnson RJ, Rawstron AC, Richards S, Morgan GJ, Norfolk DR, Hillmen SO. Johnson RJ, et al. Blood. 1998 Jun 15;91(12):4504-8. Blood. 1998. PMID: 9616145 Free article.

10

The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.

Rawstron AC, Rollinson SJ, Richards S, Short MA, English A, Morgan GJ, Hale G, Hillmen P. Rawstron AC, et al. Among authors: richards s. Br J Haematol. 1999 Oct;107(1):148-53. doi: 10.1046/j.1365-2141.1999.01676.x. Br J Haematol. 1999. PMID: 10520035 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters